Assessment of osteoprotegerin and RANKL levels and several cardiovascular risk scoring systems in acromegaly
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s42000-023-00509-8.pdf
Reference26 articles.
1. Zhang L, Zeng F, Jiang M, Han M, Huang B (2022) Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling. Front Cell Dev Biol 10:1005681. https://doi.org/10.3389/fcell.2022.1005681
2. Monseu M, Dubois S, Boursier J, Aube C, Gagnadoux F, Leftheriotis G, Ducluzeau PH (2016) Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults. Diabetes Metab 42:364–367. https://doi.org/10.1016/j.diabet.2016.02.004
3. Harper E, Forde H, Davenport C, Rochfort KD, Smith D, Cummins PM (2016) Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL. Vascul Pharmacol 82:30–40. https://doi.org/10.1016/j.vph.2016.02.003
4. Callegari A, Coons ML, Ricks JL, Yang HL, Gross TS, Huber P, Rosenfeld ME, Scatena M (2013) Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. Arterioscler Thromb Vasc Biol 33:2491–2500. https://doi.org/10.1161/ATVBAHA.113.301755
5. Harsha MM, Tewari S, Gupta SK, Khanna R, Kumar S, Garg N, Kapoor A, Goel PK (2021) Acromegaly: cardiovascular risk factors, cardiovascular manifestations and early vascular alterations in relation to disease activity. Indian Heart J 73:499–502. https://doi.org/10.1016/j.ihj.2021.05.005
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genetics of primary hyperparathyroidism, our first Batrinos’ scholar review, metabolic syndrome, and quite a bit of reproductive endocrinology: a great issue;Hormones;2024-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3